Trial intelligence / Profile preview

Immunologic response after COVID-19 vaccination in kidney transplant recipients

TCTR20210611006Recruiting

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
May 2021
Countries
1
01

Overview

Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Immunologic response to COVID-19 vaccination. Started May 2021; status: recruiting.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on TCTR20210611006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210611006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call